Skip to content

Abstract C140: Allele-specific chromatin architecture links an ancestry-associated germline variant to LRIG1 epigenetic regulation in breast cancer

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · 0 citations

Abstract

Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is a tumor suppressor gene that encodes a pan-negative regulator of receptor tyrosine kinase signaling whose loss is associated with poor prognosis, endocrine therapy resistance, and accelerated tumor growth in breast cancer. LRIG1 loss is observed in approximately 30% of breast tumors, but there is variability in this loss of expression by population groups. We previously identified significant downregulation and hypomethylation of LRIG1 at the cg26131019 locus in breast tumor tissue from African American (AA) women living in socioeconomically deprived neighborhoods in the Baltimore, Maryland area. Following these findings, we aimed to elucidate the underlying mechanism that links the epigenetic regulation of LRIG1 to its gene silencing in breast cancer. We identified rs1403626 (G<C) as an ancestry-associated germline risk variant. We hypothesized that rs1403626 functions as a regulatory element that alters allele-specific LRIG1 methylation to modulate chromatin architecture and gene expression in breast cancer. In the NCI-Maryland breast cancer study cohort, we genotyped the LRIG1 SNP rs1403626 in 326 breast tissue DNA samples using Taqman probes. To identify associations between rs1403626 genotype and LRIG1 CpG site methylation patterns, we performed a cis-methylation quantitative trait loci (cis-meQTL) analysis using the sample genotypes and normalized DNA methylation beta-values. We performed a secondary analysis of bulk ATAC-seq data in the GSE223182 dataset from Harris et al. to determine the genotype dependent chromatin accessibility at rs1403626 across triple-negative breast cancer (TNBC) cells lines derived from donors of varying ancestry. Additionally, a FIMO motif analysis was performed to identify likely allele-specific transcription factor (TF) binding candidates. In the cis-meQTL analysis, rs1403626 was identified as a cis-meQTL for the cg26131019 LRIG1 CpG site in AA control samples (FDR p-value<0.0001, beta-value=-0.015), while the association was not significant in EA control samples. This result did not vary by neighborhood deprivation status. In the secondary analysis of bulk ATAC-seq data in TNBC cell lines, HCC1806 (African ancestry: 80.7%, rs1403626: GG) had discernably lower chromatin accessibility at rs1403626 compared to MDA-MD-231 (African ancestry: 2.0%. rs1403626: CC), while HCC70 (African ancestry: 70.9%, rs1403626: GC) had an intermediate measure of chromatin accessibility. Lastly, the FIMO motif analysis identified three G allele-specific TF binding candidates, but none specific to the C allele. These results demonstrate a germline-epigenetic axis at rs1403626 that regulates LRIG1 methylation and expression in breast cancer in an ancestry-specific manner. Ongoing and future work will test how rs1403626 genotype affect gene expression, protein function, and receptor signaling and define its therapeutic implications. Angel H. Pajimola, Kyriaki Founta, Amber Yu, Alexandra Harris, Nyasha Chambwe, Brittany Jenkins-Lord. Allele-specific chromatin architecture links an ancestry-associated germline variant to LRIG1 epigenetic regulation in breast cancer [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr C140.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.